OTTAVA moves from development to commercial reality

Johnson & Johnson OTTAVA robotic surgical system with multiple articulated arms surrounding an operating table

Johnson & Johnson’s OTTAVA has reached an important milestone: its first commercial customer. Memorial Hermann-Texas Medical Center in Houston will become the first hospital to install the OTTAVA™ Robotic Surgical System, marking the beginning of its commercial introduction in the United States.

OTTAVA takes a rather different architectural approach to soft-tissue robotic surgery. Its four robotic arms are integrated directly into a standard operating table, rather than mounted on a conventional mobile patient-side cart. The concept aims to reduce OR footprint, simplify workflow and maintain flexibility around the operating table.

The announcement follows FDA De Novo authorization in July 2026 for ten upper-abdominal general surgery procedures, including gastric bypass, gastrectomy and cholecystectomy.

Johnson & Johnson MedTech logo in red

This is an important step for J&J in a market that is becoming increasingly competitive. But the real test begins now: how will this architecture perform in everyday surgical practice? Will its integration into the operating table translate into meaningful improvements in workflow, ergonomics and clinical outcomes?

J Granell. Nov 22, 2026

Also see OTTAVA (J&J´s Robotic Surgical System) Moves Closer to Market (Jan 8, 2026), FDA market authorization for OTTAVA™ robotic surgical system (Jul 22, 2026), and Names in robotic surgery (Oct 7, 2026)

Head Neck Robotic Surgery logo with the tagline "Tech Improving Outcomes"

Leave a Reply